MDDV.F Stock Overview
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Medical Developments International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.35 |
| 52 Week High | AU$0.71 |
| 52 Week Low | AU$0.29 |
| Beta | 1.63 |
| 11 Month Change | 0% |
| 3 Month Change | -9.61% |
| 1 Year Change | n/a |
| 33 Year Change | -91.24% |
| 5 Year Change | n/a |
| Change since IPO | -94.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDDV.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 2.2% |
| 1Y | n/a | 9.9% | 31.6% |
Return vs Industry: Insufficient data to determine how MDDV.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how MDDV.F performed against the US Market.
Price Volatility
| MDDV.F volatility | |
|---|---|
| MDDV.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MDDV.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MDDV.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | n/a | Brent MacGregor | medicaldev.com |
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures.
Medical Developments International Limited Fundamentals Summary
| MDDV.F fundamental statistics | |
|---|---|
| Market cap | US$32.48m |
| Earnings (TTM) | -US$27.48m |
| Revenue (TTM) | US$22.22m |
1.5x
P/S Ratio-1.2x
P/E RatioIs MDDV.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDDV.F income statement (TTM) | |
|---|---|
| Revenue | AU$33.15m |
| Cost of Revenue | AU$8.78m |
| Gross Profit | AU$24.37m |
| Other Expenses | AU$65.36m |
| Earnings | -AU$40.99m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.36 |
| Gross Margin | 73.50% |
| Net Profit Margin | -123.66% |
| Debt/Equity Ratio | 0% |
How did MDDV.F perform over the long term?
See historical performance and comparison